ArticleJournal of neuroendovascular therapy2025
Superselective Embolization of a Cavernous Sinus Dural Arteriovenous Fistula in a Patient with Moyamoya Disease.
Article in Journal of neuroendovascular therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Moyamoya disease and dural arteriovenous fistulas (dAVFs) are both rare conditions, and their coexistence is extremely uncommon. The causal relationship between moyamoya disease and cavernous sinus dAVFs (CS-dAVFs) remains unclear. We report a successfully treated case of CS-dAVF in a patient with moyamoya disease, focusing on vascular structural changes and potential pathophysiological associations. Case Presentation: A 69-year-old man with a history of moyamoya disease presented with progressive left ocular symptoms. Imaging studies, including 3D-DSA, revealed a CS-dAVF supplied by multiple feeders and draining into the superior ophthalmic and angular veins. Compared to previous imaging, the progression of moyamoya disease was evident, with worsening middle cerebral artery stenosis and increased collateral vessels. Superselective transvenous embolization was performed under general anesthesia. Microcatheters were navigated into the affected venous structures, and coil embolization successfully obliterated the shunt. Postoperatively, the patient had significant symptomatic improvement, with no moyamoya-related complications, and was discharged on postoperative day 4. Conclusion: To our knowledge, this is the first report of a successfully treated CS-dAVF in a patient with moyamoya disease. Superselective transvenous embolization was successfully performed, which led to a favorable outcome despite the presence of moyamoya disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.